node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
LOC109952337 | LOC109955317 | ENSMALP00000032489 | ENSMALP00000026701 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Tyrosine-protein kinase receptor. | 0.975 |
LOC109952337 | LOC109955690 | ENSMALP00000032489 | ENSMALP00000012032 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin receptor substrate 2a. | 0.961 |
LOC109952337 | LOC109959979 | ENSMALP00000032489 | ENSMALP00000025000 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.903 |
LOC109952337 | LOC109966709 | ENSMALP00000032489 | ENSMALP00000011329 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin-like growth factor 1a receptor. | 0.975 |
LOC109952337 | LOC109968712 | ENSMALP00000032489 | ENSMALP00000029823 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.901 |
LOC109952337 | LOC109969948 | ENSMALP00000032489 | ENSMALP00000001453 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Tyrosine-protein kinase receptor. | 0.975 |
LOC109952337 | grb2 | ENSMALP00000032489 | ENSMALP00000006296 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Growth factor receptor-bound protein 2b. | 0.569 |
LOC109955317 | LOC109952337 | ENSMALP00000026701 | ENSMALP00000032489 | Tyrosine-protein kinase receptor. | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.975 |
LOC109955317 | LOC109955690 | ENSMALP00000026701 | ENSMALP00000012032 | Tyrosine-protein kinase receptor. | Insulin receptor substrate 2a. | 0.972 |
LOC109955317 | LOC109959979 | ENSMALP00000026701 | ENSMALP00000025000 | Tyrosine-protein kinase receptor. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.968 |
LOC109955317 | LOC109966709 | ENSMALP00000026701 | ENSMALP00000011329 | Tyrosine-protein kinase receptor. | Insulin-like growth factor 1a receptor. | 0.902 |
LOC109955317 | LOC109968712 | ENSMALP00000026701 | ENSMALP00000029823 | Tyrosine-protein kinase receptor. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.975 |
LOC109955317 | LOC109969948 | ENSMALP00000026701 | ENSMALP00000001453 | Tyrosine-protein kinase receptor. | Tyrosine-protein kinase receptor. | 0.902 |
LOC109955317 | grb2 | ENSMALP00000026701 | ENSMALP00000006296 | Tyrosine-protein kinase receptor. | Growth factor receptor-bound protein 2b. | 0.958 |
LOC109955317 | mtor | ENSMALP00000026701 | ENSMALP00000010977 | Tyrosine-protein kinase receptor. | Serine/threonine-protein kinase TOR. | 0.465 |
LOC109955690 | LOC109952337 | ENSMALP00000012032 | ENSMALP00000032489 | Insulin receptor substrate 2a. | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.961 |
LOC109955690 | LOC109955317 | ENSMALP00000012032 | ENSMALP00000026701 | Insulin receptor substrate 2a. | Tyrosine-protein kinase receptor. | 0.972 |
LOC109955690 | LOC109959979 | ENSMALP00000012032 | ENSMALP00000025000 | Insulin receptor substrate 2a. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.928 |
LOC109955690 | LOC109961044 | ENSMALP00000012032 | ENSMALP00000022313 | Insulin receptor substrate 2a. | Component of inhibitor of nuclear factor kappa B kinase complex. | 0.919 |
LOC109955690 | LOC109966709 | ENSMALP00000012032 | ENSMALP00000011329 | Insulin receptor substrate 2a. | Insulin-like growth factor 1a receptor. | 0.973 |